May 2015 Skin & Eye Health

Statin Use May Increase Cataracts Risk

May 20, 2015

Eye Health Watch

While statins are among the most commonly prescribed medications for the prevention of cardiovascular disease, a recent study suggests that the use of statins may increase a patient's risk of developing cataracts.

Ranibizumab Found to Reverse Diabetes-Related Vision Loss

May 20, 2015

Eye Health Watch

Ranibizumab (Lucentis), a prescription drug frequently used to treat age-related vision loss, can also improve vision in patients with diabetic retinopathy and diabetic macular edema, a recent study indicated.

Common Antibiotics Equally Effective in Treating Uncomplicated Skin Infections

May 20, 2015

Skin Health Watch

A recent study that set out to determine which of 2 common antibiotics- clindamycin and trimethoprim sulfamethoxazole (TMP-SMX)- was the better treatment for skin infections found that both medications yielded similar success rates in curing uncomplicated infections.

Coffee Consumption May Reduce Malignant Melanoma Risk

May 20, 2015

Skin Health Watch

Whereas previous research indicated that coffee consumption may protect against nonmelanoma skin cancers, a recent study suggested that drinking coffee could decrease a patient's risk of developing malignant melanoma as well.

Next IT Virtual Health Assistant: Engaging Patients and Improving Their Outcomes

May 19, 2015

Technology News

As health care technology continues to advance, novel approaches are being cultivated and marketed to encourage patients to be proactive about their health and/or more compliant with their medical therapies.

Liability for Refusal of Controlled Prescriptions from a Prescriber

May 19, 2015

Legal Focus

When the DEA requests that several pharmacies send a letter to a prescriber indicating that they will no longer honor prescriptions from his office for certain controlled substances, may the physician initiate a lawsuit against one of the pharmacies alleging violation of his property rights without due process of law?

Keytruda

May 14, 2015

Rx Product News Profile

The FDA has approved Merck's Keytruda injection for the treatment of patients with unresectable or metastatic melanoma and disease progression following administration of ipilimumab and, if positive for the BRAF V600 mutation, a BRAF inhibitor.

Sun Damage: Protecting the Skin and Eyes

May 11, 2015

OTC Focus

Many individuals attempt to be proactive about their overall health, but they often underestimate the importance of taking care of their skin-that is, until a dermatologic issue occurs.